InvestorsHub Logo

edbi46

10/01/22 9:41 AM

#299863 RE: ddls #299856

PAY REAL ATTENTION, ddls yo, it is a Crystal Bright FUTURE for BIEL, this Company is a WINNER and Actipatch ABSOLUTELY is marketable !!!
INCREASING SALES --- HUGE!!!!!
.05c is ABSOLUTELY DOABLE
.10c is VERY DOABLE
.20c is PROBABLY DOABLY -- ALL BEFORE any share structure attention !!!!!!!
BIEL$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

srinsocal

10/02/22 2:59 PM

#299899 RE: ddls #299856

Must be looking at the wrong stock, BIEL has 5 FDA Indications via 4 510Ks

K022404 - 8/8/2002, For the treatment of edema following Blepharoplasty

K152432 - 2/3/2017, Adjunctive treatment of musculoskeletal pain related to: (1) plantar fasciitis of the heel; and (2) osteoarthritis of the knee.

K190251 - 5/30/2019, Adjunctive treatment of postoperative pain

K192234 - 1/31/2020, Adjunctive treatment of musculoskeletal pain